Compare Stocks

Date Range: 

 TRxADE HEALTHBioasis TechnologiesMedizone InternationalChina MedicineScripsAmerica
Price Information
Current Price$4.38$0.26$0.01$0.05$0.00
52 Week RangeBuyN/AN/AN/AN/A
Overall Score1.
Analysis Score3.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$12.50N/AN/AN/AN/A
% Upside from Price Target185.39% upsideN/AN/AN/AN/A
Trade Information
Market Cap$35.45 million$18.76 million$3.66 million$1.14 million$533,000.00
Average Volume1,853,88150,1355,542,79353,730562,837
Sales & Book Value
Annual Revenue$17.12 million$460,000.00N/AN/AN/A
Price / Sales2.0740.78N/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.07 per share($0.03) per shareN/AN/AN/A
Price / Book4.09-8.67N/AN/AN/A
Net Income$-2,540,000.00$-3,060,000.00N/AN/AN/A
Trailing P/E Ratio0.00N/A0.000.000.00
Forward P/E Ratio25.76
Net Margins-18.74%N/AN/AN/AN/A
Return on Equity (ROE)-35.59%-61.65%N/AN/AN/A
Return on Assets (ROA)-31.28%47.07%N/AN/AN/A
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/A0.19%N/AN/AN/A
Current Ratio7.39%1.70%N/AN/AN/A
Quick Ratio7.02%1.70%N/AN/AN/A
Ownership Information
Institutional Ownership Percentage13.70%N/AN/AN/AN/A
Insider Ownership Percentage53.30%N/A4.05%29.70%N/A
Shares Outstanding8.09 million72.14 million406.52 million24.06 million136.61 million
Next Earnings Date7/26/2021 (Estimated)7/26/2021 (Estimated)N/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
No headlines for this company have been tracked by

3/30/2021TRxADE HEALTHColliers SecuritiesReiterated Rating
2/26/2021TRxADE HEALTHMaxim GroupInitiated Coverage
12/3/2020TRxADE HEALTHNational SecuritiesInitiated Coverage
6/10/2020TRxADE HEALTHTaglich BrothersReiterated Rating
4/30/2020TRxADE HEALTHDougherty & CoReiterated Rating
(Data available from 6/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.